Healthcare Equipment and Supplies
Company Overview of Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc., a medical technology company, engages in the development, sale, and service of proton beam radiation therapy systems for radiation treatment of cancer patients. It offers MEVION S250, a proton radiation therapy device for use in patient imaging, positioning, monitoring, motion management, and clinical workflow. The company markets its product to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers worldwide. It has strategic partnership with RaySearch Laboratories AB to develop advanced treatment planning solutions. The company was formerly kno...
300 Foster Sreet
Littleton, MA 01460
Founded in 2004
Key Executives for Mevion Medical Systems, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer and Vice President
Vice President of Operations
Vice President of Regulatory Affairs & Quality Assurance and Administration
Compensation as of Fiscal Year 2014.
Mevion Medical Systems, Inc. Key Developments
Mevion Medical Systems and Philips Radiation Oncology Systems Collaborate to Offer Advanced Treatment planning Solutions for Mevion’s New Pencil Beam Scanning Technology
Oct 27 14
Mevion Medical Systems and Philips Radiation Oncology Systems are collaborating to combine the treatment planning capability of Philips’ Pinnacle³ radiation therapy planning system with the MEVION S250 solution with HYPERSCAN, Mevion’s new pencil beam scanning technology that is capable of scanning a tumor in seconds. Pinnacle currently supports the MEVION S250, the world’s smallest proton therapy platform. The new collaboration will focus on enabling the Pinnacle³ system to also support HYPERSCAN. The first site to use Pinnacle with the MEVION S250 is the UF Health Cancer Center at Orlando Health. HYPERSCAN has not been cleared by the USFDA for clinical use.
Mevion Medical Systems, Inc. and RaySearch Laboratories AB Announces Strategic Partnership to Develop Advanced Treatment Planning Solutions for the MEVION S250 with Hyperscan
Sep 15 14
Mevion Medical Systems Inc. and RaySearch Laboratories AB are announcing a partnership to develop advanced treatment planning solutions for the MEVION S250 proton therapy platform. RaySearch's RayStation(R) treatment planning system supports the MEVION S250's current configuration so this new partnership will focus on validating the use of the RayStation treatment planning system for Mevion's new HYPERSCAN pencil beam scanning technology, and developing advanced planning solutions that take advantage of HYPERSCAN's rapid pencil beam delivery capabilities. Mevion and RaySearch are partnering to provide treatment planning systems for the MEVION S250 with HYPERSCAN technology. The partnership is being announced at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), held September 14 - 16 in San Francisco. HYPERSCAN's patented technology, paired with the direct and efficient proton beam generation of the MEVION S250 platform, allows tumor volumes to be quickly scanned in a matter of seconds. This speed makes HYPERSCAN's treatment delivery much less sensitive to patient and tumor motion.
Mevion Medical Systems Introduces HYPERSCAN for the MEVION S250 Platform
Sep 11 14
Mevion Medical Systems introduced HYPERSCAN for the MEVION S250, the only modular, single room proton therapy system. Benefiting from direct and efficient proton beam generation, HYPERSCAN's patented technology allows radiation to be precisely delivered using a sharp beam of radiation, with the tumor being volumetrically scanned in a matter of seconds. Current pencil beam delivery systems are known to be sensitive to motion which can result in higher treatment uncertainties. HYPERSCAN's fast beam delivery is much less sensitive to patient and tumor motions, thus delivering a more robust treatment. HYPERSCAN is debuting at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), held September 14 -- 16 in San Francisco. Mevion representatives will formally introduce HYPERSCAN at booth 728 in the exhibit hall. HYPERSCAN is built on the MEVION S250 proton therapy platform that has been operating clinically since December 2013. The HYPERSCAN system features rapid volumetric and layer rescanning, a streamlined image-based clinical workflow, sub-millimeter position tracking, and beam gating connectivity. Simultaneously, Mevion is announcing it has reached an agreement with a financial services provider to offer financing to customers interested in purchasing the MEVION S250. This will provide Mevion's customers with an alternative to traditional financing structures, should they desire it.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|